| __timestamp | Amphastar Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 91813000 |
| Thursday, January 1, 2015 | 251519000 | 178203000 |
| Friday, January 1, 2016 | 255165000 | 216080000 |
| Sunday, January 1, 2017 | 240175000 | 241203000 |
| Monday, January 1, 2018 | 294666000 | 214109000 |
| Tuesday, January 1, 2019 | 322357000 | 204890000 |
| Wednesday, January 1, 2020 | 349846000 | 227976000 |
| Friday, January 1, 2021 | 437768000 | 356128000 |
| Saturday, January 1, 2022 | 498987000 | 426409000 |
| Sunday, January 1, 2023 | 644395000 | 837999000 |
Data in motion
In the dynamic world of pharmaceuticals, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, HUTCHMED (China) Limited and Amphastar Pharmaceuticals, Inc. have been neck and neck in this financial race. From 2014 to 2023, Amphastar's revenue grew steadily, peaking in 2023 with a remarkable 206% increase from its 2014 figures. Meanwhile, HUTCHMED, starting with a modest revenue in 2014, saw an impressive surge, culminating in a 813% increase by 2023. This dramatic rise allowed HUTCHMED to surpass Amphastar in 2023, generating 30% more revenue. The data highlights the competitive nature of the pharmaceutical industry and underscores the importance of strategic growth and market adaptation. As these companies continue to innovate, their financial trajectories will be closely watched by investors and industry analysts alike.
Revenue Showdown: Eli Lilly and Company vs Amphastar Pharmaceuticals, Inc.
Comparing Revenue Performance: Novartis AG or HUTCHMED (China) Limited?
Vertex Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Amphastar Pharmaceuticals, Inc.
argenx SE and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Viatris Inc. and HUTCHMED (China) Limited Performance Compared
Breaking Down Revenue Trends: Catalent, Inc. vs HUTCHMED (China) Limited
MorphoSys AG or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: HUTCHMED (China) Limited vs Galapagos NV
Revenue Showdown: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Amphastar Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Amphastar Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.